BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Grassi A, Ballardini G. Hepatitis C in injection drug users: It is time to treat. World J Gastroenterol 2017; 23(20): 3569-3571 [PMID: 28611509 DOI: 10.3748/wjg.v23.i20.3569]
URL: https://www.wjgnet.com/1948-5182/full/v23/i20/3569.htm
Number Citing Articles
1
Abdolhalim Rajabi, Heidar Sharafi, Seyed Moayed Alavian. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysisHarm Reduction Journal 2021; 18(1) doi: 10.1186/s12954-020-00441-9
2
Erin Kelty, Agata Chrzanowska, David B. Preen. Handbook of Substance Misuse and Addictions2022; : 1851 doi: 10.1007/978-3-030-92392-1_96
3
Javier Crespo, Pablo Lázaro, Antonio Javier Blasco, Antonio Aguilera, Javier García-Samaniego, José María Eiros, José Luis Calleja, Federico García. Diagnóstico en un solo paso de la hepatitis C en 2019: una realidad en EspañaEnfermedades Infecciosas y Microbiología Clínica 2021; 39(3): 119 doi: 10.1016/j.eimc.2020.03.004
4
C. Corey Hardin, Katherine M. Rich, Daniel A. Solomon. Medical Complications of Injection Drug Use — Part IINEJM Evidence 2023; 2(3) doi: 10.1056/EVIDra2300019
5
Erin Kelty, Agata Chrzanowska, David B. Preen. Handbook of Substance Misuse and Addictions2022; : 1 doi: 10.1007/978-3-030-67928-6_96-1
6
Michal Ordak, Tadeusz Nasierowski, Karolina Pawlik, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Effectiveness of the methadone programme in the treatment of patients on a mephedrone binge and dependent on heroin: a retrospective study, 2010–19International Journal of Psychiatry in Clinical Practice 2020; 24(3): 322 doi: 10.1080/13651501.2020.1771375
7
Anissa Chouikha, Amine Ghrabi, Amira Ghodbane, Walid Hammemi, Marwa Khedhiri, Amel Sadraoui, Henda Touzi, Hichem Ben Hassine, Sonia Maatoug, Chaima Bensaoud, Sonia Abdelhak, Samir Bouarrouj, Mariem Gdoura, Hedia Chaouachi, Henda Triki. Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination GoalFrontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.697859
8
Allison E. Wang, Eric Hsieh, Barbara J. Turner, Norah Terrault. Integrating Management of Hepatitis C Infection into Primary Care: the Key to Hepatitis C Elimination EffortsJournal of General Internal Medicine 2022; 37(13): 3435 doi: 10.1007/s11606-022-07628-9
9
Andrew H Talal, Phyllis Andrews, Anthony Mcleod, Yang Chen, Clewert Sylvester, Marianthi Markatou, Lawrence S Brown. Integrated, Co-located, Telemedicine-based Treatment Approaches for Hepatitis C Virus Management in Opioid Use Disorder Patients on MethadoneClinical Infectious Diseases 2019; 69(2): 323 doi: 10.1093/cid/ciy899
10
Kimberly Dion, Lisa Chiodo, Liz Whynott, Brita Loftus, Pedro Alvarez, Jillian Shanahan, Gabriel Quaglia, Antonio Roman, Elizabeth Sorbi, Donna Wilkins-Carmody. Exploration of the unmet health care needs of people who inject drugsJournal of the American Association of Nurse Practitioners 2020; 32(1): 60 doi: 10.1097/JXX.0000000000000201
11
Jorge Valencia La Rosa, Pablo Ryan, Alejandro Alvaro-Meca, Jesús Troya, Guillermo Cuevas, Jorge Gutiérrez, Santiago Moreno, Jason Blackard. HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV eliminationPLOS ONE 2018; 13(10): e0204795 doi: 10.1371/journal.pone.0204795
12
Javier Crespo, Pablo Lázaro de Mercado, Antonio Javier Blasco Bravo, Antonio Aguilera Guirao, Javier García-Samaniego Rey, José María Eiros Bouza, José Luis Calleja Panero, Federico García. El diagnóstico de la infección por el virus de la hepatitis C en España: una oportunidad para mejorarEnfermedades Infecciosas y Microbiología Clínica 2019; 37(4): 231 doi: 10.1016/j.eimc.2018.05.016
13
Javier Crespo, Pablo Lázaro de Mercado, Antonio Javier Blasco Bravo, Antonio Aguilera Guirao, Javier García-Samaniego Rey, José María Eiros Bouza, José Luis Calleja Panero, Federico García. Diagnosis of hepatitis C virus infection in Spain: An opportunity to improveEnfermedades infecciosas y microbiologia clinica (English ed.) 2019; 37(4): 231 doi: 10.1016/j.eimce.2019.02.006
14
Masoud Behzadifar, Meysam Behzadifar, Nicola Luigi Bragazzi. A systematic review and meta-analysis of the prevalence of hepatitis C virus infection in people who inject drugs in IranBMC Public Health 2020; 20(1) doi: 10.1186/s12889-020-8175-1
15
Sulochan GC, Ashok Khanal, Vijay S. GC, Suman Bhattarai, Suresh Panthee, Aashis Khanal, Amrit Gaire, Sagar Poudel, Rakesh Ghimire, Sharada P. Wasti, Huachun Zou. Burden of tuberculosis and hepatitis co-infection among people living with HIV in Nepal: a systematic review and meta-analysisSexual Health 2022; 19(5): 406 doi: 10.1071/SH21216
16
Branka Petković, Srđan Kesić, Slavica Ristić, Željko Pavković, Jelena Podgorac, Gordana Stojadinović, Vesna Pešić. A New Look at an Old Drug: Cumulative Effects of Low Ribavirin Doses in Amphetamine-Sensitized RatsCurrent Pharmaceutical Design 2020; 26(31): 3884 doi: 10.2174/1381612826666200326125821
17
Shoshana H Bardach, Amanda N Perry, Elizabeth Eccles, Elizabeth A Carpenter-Song, Ryan Fowler, Erin M Miers, Anais Ovalle, David de Gijsel. Coproduction of Low-Barrier Hepatitis C Virus and HIV Care for People Who Use Drugs in a Rural Community: Brief Qualitative ReportJournal of Participatory Medicine 2023; 15: e47395 doi: 10.2196/47395
18
Nativa Helena Alves Del‐Rios, Lyriane Apolinário de Araujo, Regina Maria Bringel Martins, Rafael Alves Guimarães, Márcia Alves Dias de Matos, Karlla Antonieta Amorim Caetano, Raquel Silva Pinheiro, Divânia Dias da Silva França, Leandro Nascimento da Silva, Sheila Araújo Teles, Megmar Aparecida dos Santos Carneiro. Molecular and epidemiological aspects of hepatitis C virus infection among crack cocaine usersJournal of Medical Virology 2020; 92(8): 1239 doi: 10.1002/jmv.25632
19
Stephen A. Martin, Jordon Bosse, Amanda Wilson, Phyllis Losikoff, Lisa Chiodo. Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction careAddiction Science & Clinical Practice 2018; 13(1) doi: 10.1186/s13722-018-0111-7
20
Javier Crespo, José María Eiros Bouza, Antonio Javier Blasco Bravo, Pablo Lázaro de Mercado, Antonio Aguilera Guirao, Federico García, Javier García-Samaniego Rey, José Luis Calleja Panero. The efficiency of several one-step testing strategies for the diagnosis of hepatitis CRevista Española de Enfermedades Digestivas 2018; 111 doi: 10.17235/reed.2018.5810/2018
21
Zunirah Ahmed, Akshay Shetty, David W Victor, Sudha Kodali. Viral hepatitis: A narrative review of hepatitis A–EWorld Journal of Meta-Analysis 2022; 10(3): 99-121 doi: 10.13105/wjma.v10.i3.99
22
Michal Ordak, Tadeusz Nasierowski, Elzbieta Muszynska, Magdalena Bujalska-Zadrozny. Psychoactive Substances Taken with Mephedrone and HCV InfectionJournal of Clinical Medicine 2021; 10(15): 3218 doi: 10.3390/jcm10153218
23
Farzin Khorvash, Behrooz Ataei, Zahra Baghersad, Zahra Boroumandfar. Effectiveness of the Educational-Supportive Program to Improve the Quality of Life Among Patients with Hepatitis C virus (HCV): A Quasi-Experimental StudyJundishapur Journal of Health Sciences 2022; 14(2) doi: 10.5812/jjhs-121626
24
Javier Crespo, Pablo Lázaro, Antonio Javier Blasco, Antonio Aguilera, Javier García-Samaniego, José María Eiros, José Luis Calleja, Federico García. Hepatitis C reflex testing in Spain in 2019: A story of successEnfermedades infecciosas y microbiologia clinica (English ed.) 2021; 39(3): 119 doi: 10.1016/j.eimce.2020.03.005
25
Miranda S. Moore, Angelica Bocour. Association Between Time to First RNA-Negative Test Result Among People With Hepatitis C Virus Infection and Homelessness or Testing at a Correctional or Substance Use Treatment Facility, New York CityPublic Health Reports 2022; 137(6): 1126 doi: 10.1177/00333549211049263